Table 2 Clinical and laboratory characteristics of 142 patients
Duration from diagnosis of chronic kidney disease to commencing hemodialysis (months) | |
<1 | 37 % (53/142) |
1–10 | 22 % (32/142) |
11–20 | 15 % (21/142) |
>20 | 25 % (36/142) |
Symptoms at time of diagnosis of ESRD | |
Chronic tiredness | 72 % (102/142) |
Edema | 16 % (23/142) |
Dyspnea | 12 % (17/142) |
Dialysis catheter access on admission | |
Arteriovenous fistula (FAV) | 46 % (65/142) |
Femoral vein cannulation | 36 % (52/142) |
Non-tunneled internal jugular catheter | 12 % (17/142) |
Subclavian venous cannulation | 3 % (4/142) |
Tunneled internal jugular catheter | 3 % (4/142) |
Hemoglobin concentration on admission (g/dl) | |
Median (LQ; UQ) | 8.9 (7.9; 9.8) |
Mean (± SD) | 8.8 (±1.5) |
Range | 3.7–13.1 |
Treatment | |
Having intravenous iron transfusion | 40 % (56/142) |
Having blood transfusion | 56 % (79/142) |
Patients reuse own dialyzer | 99 % (140/142) |
Duration of hemodialysis (months) | |
Median (LQ; UQ) | 27 (17; 47) |
Mean (± SD) | 40 (±40) |
Range | 1–245 |
Viral hepatitis infection status | |
HCV infection | 8 % (11/142) |
HBV infection | 8 % (11/142) |
Concurrent HCV and HBV infections | 1 % (1/142) |